Immunome (IMNM) Times Interest Earned (2019 - 2026)
Immunome (IMNM) posted Times Interest Earned of -$0.32 for Q1 2026, up 99.89% on a QoQ basis from -$299.84 in Q4 2025, and up 99.81% year-over-year from -$0.16 in Q1 2025.
Immunome (IMNM) Times Interest Earned (2019 - 2026) Analysis & Trends
Immunome's Times Interest Earned history runs 8 years deep, the most recent figure standing at -$0.32 for Q1 2026.
- Quarterly Times Interest Earned rose 99.81% year-over-year to -$0.32 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.29 (up 99.6% YoY) and the FY2025 annual result came in at -$1.24, up 56.71% from the prior year.
- Times Interest Earned was -$0.32 for Q1 2026 at Immunome, up from -$299.84 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.32 in Q1 2026 and bottomed at -$5915.8 in Q4 2023.
- A 5-year average of -$481.58 and a median of -$4.96 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned plunged 22083.35% — and 2026, when it jumped 99.81%.
- Immunome's Times Interest Earned stood at -$26.67 in 2022, then plunged by 22083.35% to -$5915.8 in 2023, then jumped by 95.31% to -$277.49 in 2024, then retreated by 8.05% to -$299.84 in 2025, then jumped by 99.89% to -$0.32 in 2026.
- Business Quant data shows IMNM's Times Interest Earned at -$0.32 in Q1 2026, -$299.84 in Q4 2025, and -$1.44 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Immunome | 2.49 Bn | 1.91 Bn | - | -0.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.32 |
| Dec 31, 2025 | -299.84 |
| Sep 30, 2025 | -1.44 |
| Jun 30, 2025 | -1.95 |
| Mar 31, 2025 | -169.08 |
| Dec 31, 2024 | -277.49 |
| Sep 30, 2024 | -0.77 |
| Jun 30, 2024 | -0.87 |
| Mar 31, 2024 | -1,322.99 |
| Dec 31, 2023 | -5,915.81 |
| Sep 30, 2023 | -0.41 |
| Jun 30, 2023 | -0.56 |
| Mar 31, 2023 | -44.71 |
| Dec 31, 2022 | -26.67 |
| Sep 30, 2022 | -2.51 |
| Jun 30, 2022 | -4.96 |
| Mar 31, 2022 | -116.54 |
| Jun 30, 2021 | -0.28 |
| Mar 31, 2021 | -38.97 |
| Dec 31, 2020 | -55.79 |